Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate Read more
Sanofi, GSK to supply 100 mn doses of COVID-19 vaccine to US, in talks with EU for 300 mn doses Read more
COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate Read more